BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
325 results:

  • 1. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Machine Learning Method for a Blood Diagnostic Model of pancreatic cancer Based on microRNA Signatures.
    Huang B; Xin C; Yan H; Yu Z
    Crit Rev Immunol; 2024; 44(3):13-23. PubMed ID: 38421702
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer Risks Associated With
    Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
    JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].
    Bräutigam K; Chouchane A; Konukiewitz B; Perren A
    Pathologie (Heidelb); 2024 Feb; 45(1):35-41. PubMed ID: 38175232
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
    Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
    Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
    Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
    Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
    Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
    Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Aneuploidy Landscape in Precursors of Ovarian cancer.
    Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
    Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.
    Vylegzhanina AV; Bespalov IA; Novototskaya-Vlasova KA; Hall BM; Gleiberman AS; Yu H; Leontieva OV; Leonova KI; Kurnasov OV; Osterman AL; Dy GK; Komissarov AA; Vasilieva E; Gehlhausen J; Iwasaki A; Ambrosone CB; Tsuji T; Matsuzaki J; Odunsi K; Andrianova EL; Gudkov AV
    Cancer Res Commun; 2023 Nov; 3(11):2256-2267. PubMed ID: 37870410
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of Glycated Hemoglobin With a Risk of pancreatic cancer in High-Risk Individuals Based on Genetic and Family History.
    Wu BU; Chen Q; Moon BH; Lustigova E; Nielsen EG; Alvarado M; Ahmed SA
    Clin Transl Gastroenterol; 2024 Jan; 15(1):e00650. PubMed ID: 37800692
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutation Analysis of pancreatic Juice and Plasma for the Detection of pancreatic cancer.
    Levink IJM; Jansen MPHM; Azmani Z; van IJcken W; van Marion R; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685923
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical Features of Li-Fraumeni Syndrome in Korea.
    Song R; Kong SY; Choi W; Lee EG; Woo J; Han JH; Lee S; Kang HS; Jung SY
    Cancer Res Treat; 2024 Jan; 56(1):334-341. PubMed ID: 37562436
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
    Fan Z; Jin M; Zhang L; Wang N; Li M; Wang C; Wei F; Zhang P; Du X; Sun X; Qiu W; Wang M; Wang H; Shi X; Ye J; Jiang C; Zhou J; Chai W; Qi J; Li T; Zhang R; Liu X; Huang B; Chai K; Cao Y; Mu W; Huang Y; Yang T; Zhang H; Qu L; Liu Y; Wang G; Lv G
    Gut; 2023 Nov; 72(11):2149-2163. PubMed ID: 37549980
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The success rates of clinical cancer next-generation sequencing based on pathologic diagnosis: Experience from a single academic laboratory.
    Latham K; Dong F
    Am J Clin Pathol; 2023 Nov; 160(5):533-539. PubMed ID: 37543867
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Current status of molecular diagnostic approaches using liquid biopsy.
    Takahashi K; Takeda Y; Ono Y; Isomoto H; Mizukami Y
    J Gastroenterol; 2023 Sep; 58(9):834-847. PubMed ID: 37470859
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
    Sun T; Gilani S; Jain D; Cai G
    Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential diagnosis?
    Dinu A; Aschie M; Cozaru GC; Mitroi AF; Grasa CN; Iordache IE; Deacu M; Orasanu CI; Nicolau AA; Baltatescu GI
    J Gastrointestin Liver Dis; 2023 Jun; 32(2):162-169. PubMed ID: 37345605
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.
    Wang Y; Ge W; Xue S; Cui J; Zhang X; Mao T; Xu H; Li S; Ma J; Yue M; Shentu D; Wang L
    IET Syst Biol; 2023 Aug; 17(4):174-186. PubMed ID: 37341253
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.